Robert F. Kennedy Jr. will be the nominee of President-elect Donald J. Trump to lead the U.S. Department of Health and Human Services (HHS). Kennedy's position on a number of public health concerns, especially those involving contentious medications like Ozempic, is called into doubt by this possible nomination.Kennedy has publicly denounced Ozempic, a medication used to treat diabetes and obesity, saying that the US could address the obesity and diabetes epidemic "overnight" if Americans were only given wholesome food. He attacked the drug's manufacturer, Novo Nordisk, in an interview with Greg Gutfeld on Fox News, charging the business with taking advantage of Americans' dependence on prescription drugs. "They’re counting on selling it to Americans because we are so stupid and so addicted to drugs," added Kennedy.Even though these are strong beliefs, if Kennedy is confirmed as Secretary of Health and Human Services, they might gain greater weight. He would have control over public health policies as a result of the position, particularly those pertaining to drug approvals and regulations.But from a position of authority, what precisely could he do about Ozempic and other medications of a similar nature?The Health Secretary Holds What Powers?The Secretary of Health and Human Services lacks the power to explicitly revoke the approval of a medication such as Ozempic, even in spite of Kennedy's outspoken objections. Drug approvals are the responsibility of the Food and Drug Administration (FDA), which is a division of HHS, not the Secretary.The FDA thoroughly evaluates medications like Ozempic before they are put on the market. The organisation evaluates the drug's efficacy and safety for the intended application. It would take strong proof that a medication is unsafe or ineffective to revoke an approved prescription. This can include fresh clinical evidence of severe adverse effects or problems with the product's production. However, the FDA, not the HHS Secretary, would have to take the first step in any such action.How Would Medicine Be Taken Off the Market?Holly Fernandez Lynch, an associate professor of law at the University of Pennsylvania and an authority on FDA drug approval standards, described the circumstances in which a medicine's clearance could be withdrawn. "Strong proof that a drug is unsafe or ineffective is one of the grounds for withdrawal," she stated.Additional causes could be the submission of false or deceptive information during the drug approval procedure, the absence of sufficient documentation or reports, or issues with drug production, including contamination or irregular formulations.Kennedy might concentrate on increasing research into the long-term impacts of medications like Ozempic or push for more regulations on prescribing practices if he wanted to press for regulatory improvements. He would not, however, be able to unilaterally revoke these medications' approval.The Limitations of the RoleAlthough the Secretary of Health and Human Services has considerable influence over public health programs, the post has little authority to actively regulate or remove medications from the market. Any significant changes in medicine availability would necessitate a wide-ranging, cooperative effort across several government branches and agencies, but a fervent opponent of Ozempic like Kennedy may push for policy changes within the FDA.Kennedy hasn't made it clear if he plans to limit access to Ozempic after he assumes office. His thoughts on the drug are still just that—thoughts—for the time being. But given his possible impact on American health policy, his position on matters like Ozempic may spark important debates and future policy recommendations.